STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
SUPN SUPERNUS PHARMACEUTICALS INCORPORATED StockScouter® Report
8
StockScouter® Score
SUPERNUS PHARMACEUTICALS INCORPORATED, a small cap growth company in the healthcare sector, is expected to outperform the market over the next six months with less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
- The multi-period measure of relative price change and consistency is above average. Positive/Neutral
- One or more less experienced analysts has modestly increased quarterly earnings estimates for SUPN. Positive/Neutral
Concerns
- Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
B
C
C
B